DRKS00023742招募中不适用
COVIDOM: Longterm morbidity of SARS-CoV-2 infection and COVID-19 disease – consequences for health status and quality of life - NAPKON - POP (National Pandemic Cohort Network - Population Based Platform)
Forschungsnetzwerk der Universitätsmedizin zu COVID-19 (Netzwerk Universitätsmedizin, NUM), Koordinierungsstelle Charité Berlin0 个研究点目标入组 3,500 人开始时间: 2020年12月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 3,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •PCR-confirmed SARS-CoV-2 infection, living in one of the target areas, age at least 18 years,
- •written informed consent.
排除标准
- •Acute SARS-CoV-2 infection or reinfection
研究者
相似试验
招募中
不适用
COVIDOM: Longterm Morbidity of SARS-CoV-2 Infection and COVID-19 Disease - Consequences for Health Status and Quality of LifeCOVID-19NCT04679584University Hospital Schleswig-Holstein2,000
已完成
不适用
Long Term Impact of COVID-19Long COVID-19Post-COVID-19 SyndromeCOVID-19NCT05813574Medisch Spectrum Twente835
已完成
不适用
ongterm outcome of patients with COVID-19 associated akut respiratory distress syndrome (cARDS)COVID-19 and Follow-upLongCOVID DiseaseJ80.0DRKS00027856niversitätsklinikum Carl Gustav Carus184
招募中
1 期
ONGITUDINAL FOLLOW-UP OF SARS-COV-2 (COVID-19) IMMUNITY IN IMMUNOCOMPROMISED POPULATIONS IN BELGIUM (COVICO)A non-commercial multicenter academic prospective cohort study during 2023-2026Healthy persons and immunocompromised patients (nursing home residents, dialysis patients and kidney- and lung transplant patients) from age 18 till age 105EUCTR2022-002531-56-BESciensano360
已完成
不适用
Mid- to longterm outcome after severe COVID-19 associated respiratory failure with Extracorporeal Membrane Oxygenation (ECMO) therapyCOVID-19-related severe hypoxemic respiratory failureDRKS00026752Herz- u. Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie60